Trimethoprim (INN) is a bacteriostatic antibiotic used mainly in the prevention and treatment of urinary tract infections. It belongs to the class of chemotherapeutic agents known as dihydrofolate reductase inhibitors. Trimethoprim was formerly marketed by GlaxoSmithKline under trade names including Proloprim, Monotrim, and Triprim; but these trade names have been licensed to various generic pharmaceutical […]

Triclabendazole, manufactured by Novartis pharmaceuticals, is an antihelminthic drug that was approved by the FDA in February 2019 for the treatment of fascioliasis in humans. Fascioliasis is a parasitic infection often caused by the helminth,?Fasciola hepatica, which is also known as “the common liver fluke” or “the sheep liver fluke” or by?Fasciola gigantica, another helminth. […]